Right heart catheterisation: best practice and pitfalls in pulmonary hypertension

por Rosenkranz, Stephan, Preston, Ioana R.
Publicado 2015

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension

por Steiner, M Kathryn, Preston, Ioana R
Publicado 2008

Safety and tolerability of bosentan in the management of pulmonary arterial hypertension

por Roberts, Kari E, Preston, Ioana R
Publicado 2009

New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension

por Preston, Ioana R., Suissa, Samy, Humbert, Marc
Publicado 2013

An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail

por Hill, Nicholas S., Farber, Harrison W., Preston, Ioana R.
Publicado 2020

Practical management of riociguat in patients with pulmonary arterial hypertension

por Halank, Michael, Tausche, Kristin, Grünig, Ekkehard, Ewert, Ralf, Preston, Ioana R.
Publicado 2019

Differences between basal lung levels of select eicosanoids in rat and mouse

por Sagliani, Kristen D., Dolnikowski, Gregory G., Hill, Nicholas S., Fanburg, Barry L., Levy, Bruce D., Preston, Ioana R.
Publicado 2013

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension

por Preston, Ioana R., Sagliani, Kristen D., Roberts, Kari E., Shah, Archan M., DeSouza, Shilpa A., Howard, William, Brennan, John, Hill, Nicholas S.
Publicado 2013

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)

por Preston, Ioana R., Roberts, Kari E., Miller, Dave P., Sen, Ginny P., Selej, Mona, Benton, Wade W., Hill, Nicholas S., Farber, Harrison W.
Publicado 2015

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)

por Howard, Luke S., Rosenkranz, Stephan, Frantz, Robert P., Hemnes, Anna R., Pfister, Thomas, Hsu Schmitz, Shu-Fang, Skåra, Hall, Humbert, Marc, Preston, Ioana R.
Publicado 2023

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

por Ghofrani, Hossein-Ardeschir, Grünig, Ekkehard, Jansa, Pavel, Langleben, David, Rosenkranz, Stephan, Preston, Ioana R., Rahaghi, Franck, Sood, Namita, Busse, Dennis, Meier, Christian, Humbert, Marc
Publicado 2020

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies

por Thenappan, Thenappan, Al-Naamani, Nadine, Ghio, Stefano, Ghofrani, Hossein-Ardeschir, Hassoun, Paul M., Pritzker, Marc, Torbicki, Adam, Nikkho, Sylvia, Busse, Dennis, Preston, Ioana R.
Publicado 2020

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)

por Hill, Nicholas S., Feldman, Jeremy P., Sahay, Sandeep, Benza, Raymond L., Preston, Ioana R., Badesch, David, Frantz, Robert P., Patel, Savan, Galloway, Ashley, Bull, Todd M.
Publicado 2022

Risk stratification and medical therapy of pulmonary arterial hypertension

por Galiè, Nazzareno, Channick, Richard N., Frantz, Robert P., Grünig, Ekkehard, Jing, Zhi Cheng, Moiseeva, Olga, Preston, Ioana R., Pulido, Tomas, Safdar, Zeenat, Tamura, Yuichi, McLaughlin, Vallerie V.
Publicado 2019

Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, pha...

por Klose, Hans, Chin, Kelly M., Ewert, Ralf, Gall, Henning, Parambil, Joseph, Poch, David, Seyfarth, Hans-Jürgen, Axelsen, Lene N., Hsu Schmitz, Shu-Fang, Stein, Claudia, Preston, Ioana R.
Publicado 2021

Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension

por Menon, Divya P., Qi, Guanming, Kim, Seung K., Moss, M. Elizabeth, Penumatsa, Krishna C., Warburton, Rod R., Toksoz, Deniz, Wilson, Jamie, Hill, Nicholas S., Jaffe, Iris Z., Preston, Ioana R.
Publicado 2021

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

por Benza, Raymond L., Langleben, David, Hemnes, Anna R., Vonk Noordegraaf, Anton, Rosenkranz, Stephan, Thenappan, Thenappan, Hassoun, Paul M., Preston, Ioana R., Ghio, Stefano, Badagliacca, Roberto, Vizza, Carmine D., Lang, Irene M., Meier, Christian, Grünig, Ekkehard
Publicado 2022

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study

por Rahaghi, Franck F., Kolaitis, Nicholas A., Adegunsoye, Ayodeji, de Andrade, Joao A., Flaherty, Kevin R., Lancaster, Lisa H., Lee, Joyce S., Levine, Deborah J., Preston, Ioana R., Safdar, Zeenat, Saggar, Rajan, Sahay, Sandeep, Scholand, Mary Beth, Shlobin, Oksana A., Zisman, David A., Nathan, Steven D.
Publicado 2022

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

por Humbert, Marc, McLaughlin, Vallerie, Gibbs, J. Simon R., Gomberg-Maitland, Mardi, Hoeper, Marius M., Preston, Ioana R., Souza, Rogerio, Waxman, Aaron B., Ghofrani, Hossein-Ardeschir, Escribano Subias, Pilar, Feldman, Jeremy, Meyer, Gisela, Montani, David, Olsson, Karen M., Manimaran, Solaiappan, de Oliveira Pena, Janethe, Badesch, David B.
Publicado 2023

The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension

por Forfia, Paul, Benza, Raymond, D'Alto, Michele, De Marco, Teresa, Elwing, Jean M., Frantz, Robert, Haddad, Francois, Oudiz, Ronald, Preston, Ioana R., Rosenkranz, Stephan, Ryan, John, Schilz, Robert, Shlobin, Oksana A., Vachiery, Jean‐Luc, Vizza, Carmine Dario, Noordegraaf, Anton Vonk, Sketch, Margaret R., Broderick, Meredith, McLaughlin, Vallerie
Publicado 2023